Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Jardiance (empagliflozin) and Invokamet (canagliflozin/metformin) are both medications used to manage Type 2 diabetes, but they have some key differences. Jardiance is a single medication that belongs to a sodium-glucose co-transporter 2 (SGLT2) inhibitor class and is taken once daily. It helps lower blood sugar by causing your body to excrete excess sugar through urine and can also reduce the risk of heart and kidney complications. Invokamet, on the other hand, is a combination of two medications: canagliflozin (an SGLT2 inhibitor) and metformin (a biguanide). It is available in both immediate-release tablets taken twice daily and extended-release tablets taken once daily. While both medications can cause urinary tract infections and genital infections, Invokamet also has a risk of lowering vitamin B12 levels and causing bone fractures. Additionally, Jardiance is currently only available as a brand-name medication, with generics expected after 2025, whereas Invokamet is also brand-only. Both medications require a prescription and should be taken with a healthy diet and exercise.
Invokamet (canagliflozin / metformin) is a combination medication used along with diet and exercise to lower blood sugar levels in adults with Type 2 diabetes. It's available as immediate-release tablets that are taken twice daily, as well as extended-release tablets that are taken once daily. This medication raises the risk of urinary tract infections (UTIs) and genital infections.
Indications of Jardiance vs. Invokamet
Indications for
•Type 2 diabetes (in addition to diet and exercise) in people age 10 years and older
•Lowering the risk of death due to heart problems in adults with Type 2 diabetes and heart disease
•Lowering the risk of hospitalization and death due to heart problems in adults with heart failure
•Lowering the risk of worsening kidney problems, hospitalization, and death due to heart problems in adults with chronic kidney disease (CKD)
Indications for
•Type 2 diabetes
•To lower the risk of major heart events (e.g., heart attack, stroke) in adults with Type 2 diabetes and heart disease
•To lower the risk of hospitalization for heart failure, death due to heart problems, and worsening of kidney problems in certain adults with Type 2 diabetes and diabetic kidney disease
•Not recommended during the second and third trimesters of pregnancy
Pros and Const for SGLT2 inhibitor / Biguanide
Pros
•Combines two medications into one pill
•Available as an extended-release tablet that lasts throughout the day (Invokamet XR)
•Can lower A1C (a blood test that measures your average sugar level over time) by up to 1.8% in people who aren't already taking either Invokana (canagliflozin) or metformin
•Dose can be adjusted based on how well the medication is working for you